Back to evidence trackerDemo-only · read-only

Internal maintenance preview

Evidence stays useful only when review is operational.

This page exposes review state and update workflow without creating a public editing endpoint. Record changes are made in typed source files, validated, tested and reviewed before publishing.

Requires attention53of 102 intelligence records

Demo admin workspace

Research and review console

Browser-local prototype · no persistence · no public mutation endpoint

Selected record

BPC-157editorially researchedcompounding status review4 source records

Provisional evidence gradeAlias to stageAuthoritative source URL

Due-for-review report

Current queue

Stale warning threshold: 90 days · Dataset 2026.08-intelligence.1

Record	Last verified	Research state	Reason	Priority
BPC-157Synthetic 15-amino-acid peptide	Aug 27, 2026	editorially researched	Not FDA approved; FDA’s 2026 503A review was active and did not itself create a final compounding rule or drug approval.	Immediate
TB-500Synthetic seven-amino-acid fragment related to thymosin beta-4	Aug 27, 2026	editorially researched	Not FDA approved; FDA’s 2026 review found no human clinical studies of TB-500 itself and did not itself create a final compounding rule.	Immediate
Acetyl hexapeptide-8Topical cosmetic hexapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Acetyl octapeptide-3Topical cosmetic octapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
AmycretinCombined GLP-1 and amylin receptor agonist peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
AmylinEndogenous pancreatic peptide hormone	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
AOD-9604Modified growth-hormone C-terminal fragment peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
ApelinEndogenous apelin-receptor peptide ligand	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
AviptadilSynthetic vasoactive intestinal peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
CardiogenShort synthetic peptide bioregulator	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
CerebrolysinPorcine brain-derived peptide mixture	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
CibinetideInnate repair receptor agonist peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
CJC-1295Long-acting growth hormone-releasing hormone analogue	Aug 27, 2026	editorially researched	Not FDA approved; FDA has identified safety and product-characterization concerns, and a 2024 advisory committee opposed 503A-list placement.	Medical review
CJC-1295 with DACLong-acting GHRH analogue with drug-affinity complex	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
CotadutideDual glucagon and GLP-1 receptor agonist peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
DavunetideActivity-dependent neuroprotective protein-derived peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Delta Sleep-Inducing PeptideExperimental endogenous-like nonapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
DihexaNon-peptide angiotensin IV-derived small molecule	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
EpitalonSynthetic tetrapeptide bioregulator	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Follistatin-344Experimental follistatin isoform protein	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
FOXO4-DRIExperimental D-retro-inverso cell-penetrating peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
GHK-CuCopper-binding tripeptide complex	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
GHRP-2Synthetic growth hormone-releasing peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
GHRP-6Synthetic growth hormone-releasing hexapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
GonadorelinSynthetic gonadotropin-releasing hormone decapeptide	Aug 27, 2026	research in progress	Historical product approvals and current market status require product-level verification.	Medical review
HexarelinSynthetic ghrelin-receptor agonist hexapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
HumaninMitochondrial-derived peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
IbutamorenNon-peptide ghrelin-receptor agonist	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
IpamorelinGhrelin-receptor agonist and growth hormone secretagogue	Aug 27, 2026	editorially researched	Not FDA approved; FDA identifies significant compounding safety concerns, and a 2024 advisory committee opposed 503A-list placement.	Medical review
KisspeptinEndogenous reproductive neuropeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
KPVAlpha-MSH-derived tripeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
LarazotideSynthetic tight-junction-modulating octapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
LL-37Endogenous antimicrobial peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Mechano Growth FactorIGF-1 splice-variant-derived peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Melanotan IISynthetic cyclic melanocortin analogue	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Modified GRF 1-29Short-acting modified GHRH fragment	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
MOTS-cMitochondrial-derived 16-amino-acid peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
N-Acetyl Selank AmidateModified experimental Selank analogue	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
N-Acetyl Semax AmidateModified experimental Semax analogue	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
P21Experimental CNTF-derived peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Palmitoyl pentapeptide-4Topical cosmetic lipopeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Palmitoyl tetrapeptide-7Topical cosmetic lipopeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Palmitoyl tripeptide-1Topical cosmetic lipopeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
PEG-MGFPEGylated experimental MGF analogue	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
PinealonShort synthetic peptide bioregulator	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
SelankSynthetic tuftsin-related heptapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
SemaxSynthetic ACTH(4-7)-related heptapeptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
SerelaxinRecombinant peptide hormone	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
SermorelinGrowth hormone-releasing hormone analogue	Aug 27, 2026	editorially researched	Prior Geref approvals were withdrawn after discontinuation; no currently marketed FDA-approved sermorelin product is established here.	Medical review
ThymalinThymic peptide extract mixture	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Thymosin alpha-1Synthetic thymic peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
Thymosin beta-4Endogenous actin-sequestering peptide	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
VesugenShort synthetic peptide bioregulator	Aug 27, 2026	research in progress	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Medical review
AbaloparatideParathyroid hormone-related protein analogue peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
AfamelanotideAlpha-MSH analogue peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
Angiotensin IISynthetic human angiotensin II peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
ApraglutideLong-acting GLP-2 analogue peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
BivalirudinDirect thrombin-inhibitor peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
BremelanotideMelanocortin receptor agonist cyclic peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
CagrilintideLong-acting amylin analogue peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
CagriSemaInvestigational amylin analogue and GLP-1 combination	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
Calcitonin salmonCalcitonin peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
DasiglucagonGlucagon analogue peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
DesmopressinVasopressin analogue peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
DulaglutideLong-acting GLP-1 receptor agonist fusion protein	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
ElamipretideMitochondria-targeting tetrapeptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
EnfuvirtideHIV fusion-inhibitor peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
ExenatideExendin-4 GLP-1 receptor agonist peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
GlepaglutideLong-acting GLP-2 analogue peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
GlucagonPancreatic peptide hormone medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
Human chorionic gonadotropinGlycoprotein hormone	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
IcatibantBradykinin B2 receptor antagonist peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
LanreotideSomatostatin analogue cyclic peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
LeuprolideGnRH agonist peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
LinaclotideGuanylate cyclase-C agonist peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
LiraglutideGLP-1 receptor agonist peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
LixisenatideGLP-1 receptor agonist peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
MacimorelinNon-peptide ghrelin-receptor agonist diagnostic drug	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
Maridebart cafraglutideGIP receptor antibody–GLP-1 analogue conjugate	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
MazdutideDual glucagon and GLP-1 receptor agonist peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
MecaserminRecombinant insulin-like growth factor-1 protein	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
NesiritideRecombinant B-type natriuretic peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
OctreotideSomatostatin analogue octapeptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
OrforglipronNon-peptide oral GLP-1 receptor agonist	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
OxytocinEndogenous nonapeptide hormone and medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
PasireotideSomatostatin analogue cyclic peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
PegcetacoplanPEGylated complement C3 inhibitor peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
PemvidutideDual glucagon and GLP-1 receptor agonist peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
PlecanatideGuanylate cyclase-C agonist peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
PramlintideAmylin analogue peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
RetatrutideTriple GIP, GLP-1 and glucagon receptor agonist peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
SemaglutideGLP-1 receptor agonist peptide medication	Aug 27, 2026	editorially researched	FDA approved in specific products for defined metabolic, cardiovascular and liver-disease indications.	Routine
SetmelanotideMelanocortin-4 receptor agonist cyclic peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
SomatropinRecombinant protein hormone	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
SurvodutideDual glucagon and GLP-1 receptor agonist peptide	Aug 27, 2026	regulatory verified	Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.	Routine
TeduglutideGLP-2 analogue peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
TeriparatideParathyroid hormone fragment peptide medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
TesamorelinGrowth hormone-releasing factor analogue	Aug 27, 2026	editorially researched	FDA approved for reduction of excess abdominal fat in adults with HIV and lipodystrophy—not for general weight loss.	Routine
TirzepatideDual GIP and GLP-1 receptor agonist peptide medication	Aug 27, 2026	editorially researched	FDA approved in product-specific formulations for type 2 diabetes, chronic weight management and obesity-associated OSA.	Routine
TriptorelinLong-acting GnRH agonist peptide	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
VasopressinEndogenous nonapeptide hormone medication	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine
ZiconotideSynthetic conopeptide calcium-channel blocker	Aug 27, 2026	editorially researched	FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.	Routine

Safe update workflow

From source change to published record

01
Trigger review
Start with an FDA label change, shortage update, Federal Register notice, advisory action, new ClinicalTrials.gov result or material peer-reviewed study.
02
Capture the primary record
Add the direct URL, source organization, exact title, source date, evidence type and verification date through the normalized intelligence source layer.
03
Update claims narrowly
Edit only the affected identity, indication, regulatory field, caution, relationship or compounding note. Add a sourced review-history entry.
04
Validate and review
Run schema validation, tests and the due report. Physician and legal reviewers approve the exact record version before publication.
05
Publish with an audit trail
Increment the dataset version, preserve the prior record, publish, and schedule the next review interval.

Source audit

Every seeded record resolves to direct sources.

BPC-157

4 direct sources · editorially researched

U.S. Food and Drug Administration National Library of Medicine / PubMed U.S. Food and Drug Administration U.S. Food and Drug Administration

CJC-1295

4 direct sources · editorially researched

U.S. Food and Drug Administration U.S. Food and Drug Administration National Library of Medicine / PubMed U.S. Food and Drug Administration

Ipamorelin

3 direct sources · editorially researched

U.S. Food and Drug Administration U.S. Food and Drug Administration National Library of Medicine / PubMed

Semaglutide

4 direct sources · editorially researched

U.S. Food and Drug Administration National Library of Medicine / PubMed U.S. Food and Drug Administration U.S. Food and Drug Administration

Sermorelin

5 direct sources · editorially researched

U.S. Food and Drug Administration U.S. Food and Drug Administration / Federal Register National Library of Medicine / PubMed U.S. Food and Drug Administration U.S. Food and Drug Administration

TB-500

3 direct sources · editorially researched

U.S. Food and Drug Administration U.S. Food and Drug Administration U.S. Food and Drug Administration

Tesamorelin

3 direct sources · editorially researched

U.S. Food and Drug Administration National Library of Medicine / PubMed U.S. Food and Drug Administration

Tirzepatide

5 direct sources · editorially researched

U.S. Food and Drug Administration U.S. Food and Drug Administration National Library of Medicine / PubMed U.S. Food and Drug Administration U.S. Food and Drug Administration

Thymosin beta-4

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Thymosin alpha-1

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

KPV

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

LL-37

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

GHK-Cu

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Cibinetide

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Mechano Growth Factor

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

PEG-MGF

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Follistatin-344

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

CJC-1295 with DAC

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Modified GRF 1-29

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

GHRP-2

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

GHRP-6

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Hexarelin

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Ibutamoren

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Macimorelin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Somatropin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Mecasermin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Liraglutide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Retatrutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Cagrilintide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

CagriSema

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Survodutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Mazdutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Pemvidutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Orforglipron

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Exenatide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Lixisenatide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Dulaglutide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Pramlintide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Amylin

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Cotadutide

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Maridebart cafraglutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Amycretin

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Glucagon

1 direct sources · editorially researched

U.S. Food and Drug Administration

Dasiglucagon

1 direct sources · editorially researched

U.S. Food and Drug Administration

MOTS-c

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Humanin

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Elamipretide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Epitalon

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

FOXO4-DRI

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Pinealon

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Vesugen

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Cardiogen

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Thymalin

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Semax

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Selank

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Cerebrolysin

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Dihexa

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

N-Acetyl Semax Amidate

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

N-Acetyl Selank Amidate

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

P21

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Davunetide

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Delta Sleep-Inducing Peptide

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Oxytocin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Bremelanotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Kisspeptin

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Gonadorelin

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Triptorelin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Leuprolide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Human chorionic gonadotropin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Palmitoyl pentapeptide-4

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Acetyl hexapeptide-8

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Palmitoyl tripeptide-1

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Palmitoyl tetrapeptide-7

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Acetyl octapeptide-3

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Afamelanotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Melanotan II

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Larazotide

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Aviptadil

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Apelin

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Serelaxin

1 direct sources · research in progress

ClinicalTrials.gov / U.S. National Library of Medicine

Linaclotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Plecanatide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Teduglutide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Glepaglutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Apraglutide

1 direct sources · regulatory verified

ClinicalTrials.gov / U.S. National Library of Medicine

Setmelanotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Pasireotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Octreotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Lanreotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Desmopressin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Vasopressin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Calcitonin salmon

1 direct sources · editorially researched

U.S. Food and Drug Administration

Teriparatide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Abaloparatide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Nesiritide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Angiotensin II

1 direct sources · editorially researched

U.S. Food and Drug Administration

Bivalirudin

1 direct sources · editorially researched

U.S. Food and Drug Administration

Pegcetacoplan

1 direct sources · editorially researched

U.S. Food and Drug Administration

Icatibant

1 direct sources · editorially researched

U.S. Food and Drug Administration

Ziconotide

1 direct sources · editorially researched

U.S. Food and Drug Administration

Enfuvirtide

1 direct sources · editorially researched

U.S. Food and Drug Administration

AOD-9604

1 direct sources · research in progress

PubMed / U.S. National Library of Medicine

Product roadmap

What a production evidence operation needs next.

Review governance

Physician and legal review queues, record locking, approval and publishing workflow.

Versioned evidence

Immutable record versions, diffs, provenance and complete audit logs.

Source monitoring

Scheduled official-source checks, regulatory-change detection and review notifications.

Secure operations

Authenticated admin access, role-based permissions and multi-tenant clinic isolation.

Patient education

Optional physician-approved handouts generated only from published record versions.

Approved AI assistant

Retrieval limited to approved evidence versions with citation enforcement and escalation rules.

HIPAA boundary

If patient-specific questions are added, complete privacy, security, minimum-necessary, BAA, retention and audit review before handling PHI.

No CRM, Twilio, patient messaging or public write endpoint is included in this demo.

Record

Last verified

Research state

Reason

Priority

BPC-157Synthetic 15-amino-acid peptide

Aug 27, 2026

editorially researched

Not FDA approved; FDA’s 2026 503A review was active and did not itself create a final compounding rule or drug approval.

Immediate

TB-500Synthetic seven-amino-acid fragment related to thymosin beta-4

Aug 27, 2026

editorially researched

Not FDA approved; FDA’s 2026 review found no human clinical studies of TB-500 itself and did not itself create a final compounding rule.

Immediate

Acetyl hexapeptide-8Topical cosmetic hexapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Acetyl octapeptide-3Topical cosmetic octapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

AmycretinCombined GLP-1 and amylin receptor agonist peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

AmylinEndogenous pancreatic peptide hormone

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

AOD-9604Modified growth-hormone C-terminal fragment peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

ApelinEndogenous apelin-receptor peptide ligand

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

AviptadilSynthetic vasoactive intestinal peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

CardiogenShort synthetic peptide bioregulator

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

CerebrolysinPorcine brain-derived peptide mixture

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

CibinetideInnate repair receptor agonist peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

CJC-1295Long-acting growth hormone-releasing hormone analogue

Aug 27, 2026

editorially researched

Not FDA approved; FDA has identified safety and product-characterization concerns, and a 2024 advisory committee opposed 503A-list placement.

Medical review

CJC-1295 with DACLong-acting GHRH analogue with drug-affinity complex

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

CotadutideDual glucagon and GLP-1 receptor agonist peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

DavunetideActivity-dependent neuroprotective protein-derived peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Delta Sleep-Inducing PeptideExperimental endogenous-like nonapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

DihexaNon-peptide angiotensin IV-derived small molecule

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

EpitalonSynthetic tetrapeptide bioregulator

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Follistatin-344Experimental follistatin isoform protein

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

FOXO4-DRIExperimental D-retro-inverso cell-penetrating peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

GHK-CuCopper-binding tripeptide complex

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

GHRP-2Synthetic growth hormone-releasing peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

GHRP-6Synthetic growth hormone-releasing hexapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

GonadorelinSynthetic gonadotropin-releasing hormone decapeptide

Aug 27, 2026

research in progress

Historical product approvals and current market status require product-level verification.

Medical review

HexarelinSynthetic ghrelin-receptor agonist hexapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

HumaninMitochondrial-derived peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

IbutamorenNon-peptide ghrelin-receptor agonist

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

IpamorelinGhrelin-receptor agonist and growth hormone secretagogue

Aug 27, 2026

editorially researched

Not FDA approved; FDA identifies significant compounding safety concerns, and a 2024 advisory committee opposed 503A-list placement.

Medical review

KisspeptinEndogenous reproductive neuropeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

KPVAlpha-MSH-derived tripeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

LarazotideSynthetic tight-junction-modulating octapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

LL-37Endogenous antimicrobial peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Mechano Growth FactorIGF-1 splice-variant-derived peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Melanotan IISynthetic cyclic melanocortin analogue

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Modified GRF 1-29Short-acting modified GHRH fragment

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

MOTS-cMitochondrial-derived 16-amino-acid peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

N-Acetyl Selank AmidateModified experimental Selank analogue

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

N-Acetyl Semax AmidateModified experimental Semax analogue

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

P21Experimental CNTF-derived peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Palmitoyl pentapeptide-4Topical cosmetic lipopeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Palmitoyl tetrapeptide-7Topical cosmetic lipopeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Palmitoyl tripeptide-1Topical cosmetic lipopeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

PEG-MGFPEGylated experimental MGF analogue

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

PinealonShort synthetic peptide bioregulator

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

SelankSynthetic tuftsin-related heptapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

SemaxSynthetic ACTH(4-7)-related heptapeptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

SerelaxinRecombinant peptide hormone

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

SermorelinGrowth hormone-releasing hormone analogue

Aug 27, 2026

editorially researched

Prior Geref approvals were withdrawn after discontinuation; no currently marketed FDA-approved sermorelin product is established here.

Medical review

ThymalinThymic peptide extract mixture

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Thymosin alpha-1Synthetic thymic peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

Thymosin beta-4Endogenous actin-sequestering peptide

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

VesugenShort synthetic peptide bioregulator

Aug 27, 2026

research in progress

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Medical review

AbaloparatideParathyroid hormone-related protein analogue peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

AfamelanotideAlpha-MSH analogue peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

Angiotensin IISynthetic human angiotensin II peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

ApraglutideLong-acting GLP-2 analogue peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

BivalirudinDirect thrombin-inhibitor peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

BremelanotideMelanocortin receptor agonist cyclic peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

CagrilintideLong-acting amylin analogue peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

CagriSemaInvestigational amylin analogue and GLP-1 combination

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

Calcitonin salmonCalcitonin peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

DasiglucagonGlucagon analogue peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

DesmopressinVasopressin analogue peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

DulaglutideLong-acting GLP-1 receptor agonist fusion protein

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

ElamipretideMitochondria-targeting tetrapeptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

EnfuvirtideHIV fusion-inhibitor peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

ExenatideExendin-4 GLP-1 receptor agonist peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

GlepaglutideLong-acting GLP-2 analogue peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

GlucagonPancreatic peptide hormone medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

Human chorionic gonadotropinGlycoprotein hormone

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

IcatibantBradykinin B2 receptor antagonist peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

LanreotideSomatostatin analogue cyclic peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

LeuprolideGnRH agonist peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

LinaclotideGuanylate cyclase-C agonist peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

LiraglutideGLP-1 receptor agonist peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

LixisenatideGLP-1 receptor agonist peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

MacimorelinNon-peptide ghrelin-receptor agonist diagnostic drug

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

Maridebart cafraglutideGIP receptor antibody–GLP-1 analogue conjugate

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

MazdutideDual glucagon and GLP-1 receptor agonist peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

MecaserminRecombinant insulin-like growth factor-1 protein

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

NesiritideRecombinant B-type natriuretic peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

OctreotideSomatostatin analogue octapeptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

OrforglipronNon-peptide oral GLP-1 receptor agonist

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

OxytocinEndogenous nonapeptide hormone and medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

PasireotideSomatostatin analogue cyclic peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

PegcetacoplanPEGylated complement C3 inhibitor peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

PemvidutideDual glucagon and GLP-1 receptor agonist peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

PlecanatideGuanylate cyclase-C agonist peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

PramlintideAmylin analogue peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

RetatrutideTriple GIP, GLP-1 and glucagon receptor agonist peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

SemaglutideGLP-1 receptor agonist peptide medication

Aug 27, 2026

editorially researched

FDA approved in specific products for defined metabolic, cardiovascular and liver-disease indications.

Routine

SetmelanotideMelanocortin-4 receptor agonist cyclic peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

SomatropinRecombinant protein hormone

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

SurvodutideDual glucagon and GLP-1 receptor agonist peptide

Aug 27, 2026

regulatory verified

Identity is cataloged; current U.S. regulatory status requires record-level verification before publication as a medical claim.

Routine

TeduglutideGLP-2 analogue peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

TeriparatideParathyroid hormone fragment peptide medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

TesamorelinGrowth hormone-releasing factor analogue

Aug 27, 2026

editorially researched

FDA approved for reduction of excess abdominal fat in adults with HIV and lipodystrophy—not for general weight loss.

Routine

TirzepatideDual GIP and GLP-1 receptor agonist peptide medication

Aug 27, 2026

editorially researched

FDA approved in product-specific formulations for type 2 diabetes, chronic weight management and obesity-associated OSA.

Routine

TriptorelinLong-acting GnRH agonist peptide

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

VasopressinEndogenous nonapeptide hormone medication

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

ZiconotideSynthetic conopeptide calcium-channel blocker

Aug 27, 2026

editorially researched

FDA approval is product- and indication-specific; it does not establish evidence for unrelated longevity or wellness claims.

Routine

From source change to published record

Trigger review

Start with an FDA label change, shortage update, Federal Register notice, advisory action, new ClinicalTrials.gov result or material peer-reviewed study.

Capture the primary record

Add the direct URL, source organization, exact title, source date, evidence type and verification date through the normalized intelligence source layer.

Update claims narrowly

Edit only the affected identity, indication, regulatory field, caution, relationship or compounding note. Add a sourced review-history entry.

Validate and review

Run schema validation, tests and the due report. Physician and legal reviewers approve the exact record version before publication.

Publish with an audit trail

Increment the dataset version, preserve the prior record, publish, and schedule the next review interval.